Clinical Orthopaedics and Related Research®

, Volume 468, Issue 8, pp 2107–2112

Microbiology of Bone and Joint Infections in Injecting Drug Abusers

  • Daniel C. Allison
  • Paul D. Holtom
  • Michael J. Patzakis
  • Charalampos G. Zalavras
Symposium: Papers Presented at the 2009 Meeting of the Musculoskeletal Infection Society

Abstract

Background

The literature contains variable reports on the causative organisms of osteomyelitis and septic arthritis in patients with injecting drug abuse and on the rate of oxacillin-resistant S aureus. It is important to have a clear notion of the organisms to initiate empiric antimicrobial therapy.

Questions/purposes

We therefore determined the spectrum of organisms in bone and joint infections in patients who were injecting drug users.

Methods

We retrospectively reviewed the medical records of 215 patients (154 male, 61 female) with a history of injecting drug abuse and concurrent bone and/or joint infection from 1998 to 2005. The mean age was 43 years (range, 23–83 years). Osteomyelitis was present in 127 of the 215 patients (59%), septic arthritis in 53 (25%), and both in 35 (16%). The lower extremity was most commonly involved (141 cases, 66%), with osteomyelitis of the tibia present in 70 patients (33%) and septic knee arthritis in 30 patients (14%).

Results

Cultures yielded predominately Gram-positive bacteria: Staphylococcus aureus in 52% and coagulase-negative Staphylococcus in 20%. The proportion of oxacillin-resistant S aureus among S aureus infections increased from 21% in 1998 to 73% in 2005. Gram-negative organisms were present in 19% of infections and anaerobes in 13%. Patients with osteomyelitis had a higher prevalence of polymicrobial infections (46% versus 15%), infections due to Gram-negative organisms (24% versus 9%), and anaerobic infections (19% versus 6%) compared to patients with septic arthritis.

Conclusions

These findings suggest broad-spectrum empiric antibiotic therapy, including vancomycin, should be considered for bone and joint infections in patients with injecting drug abuse.

Level of Evidence

Level IV, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.

References

  1. 1.
    Allison DC, Miller T, Holtom P, Patzakis MJ, Zalavras CG. Microbiology of upper extremity soft tissue abscesses in injecting drug abusers. Clin Orthop Relat Res. 2007;461:9–13.PubMedGoogle Scholar
  2. 2.
    Ang-Fonte GZ, Rozboril MB, Thompson GR. Changes in nongonococcal septic arthritis: drug abuse and methicillin-resistant Staphylococcus aureus. Arthritis Rheum. 1985;28:210–213.CrossRefPubMedGoogle Scholar
  3. 3.
    Atkinson SR, Paul J, Sloan E, Curtis S, Miller R. The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users. J Infect. 2009;58:339–345.CrossRefPubMedGoogle Scholar
  4. 4.
    Belzunegui J, Rodriguez-Arrondo F, Gonzalez C, Queiro R, Martinez de Bujo M, Intxausti JJ, De Dios JR, Figueroa M. Musculoskeletal infections in intravenous drug addicts: report of 34 cases with analysis of microbiological aspects and pathogenic mechanisms. Clin Exp Rheumatol. 2000;18:383–386.PubMedGoogle Scholar
  5. 5.
    Brancos MA, Peris P, Miro JM, Monegal A, Gatell JM, Mallolas J, Mensa J, Garcia S, Munoz-Gomez J. Septic arthritis in heroin addicts. Semin Arthritis Rheum. 1991;21:81–87.CrossRefPubMedGoogle Scholar
  6. 6.
    Chandrasekar PH, Narula AP. Bone and joint infections in intravenous drug abusers. Rev Infect Dis. 1986;8:904–911.PubMedGoogle Scholar
  7. 7.
    Gifford DB, Patzakis M, Ivler D, Swezey RL. Septic arthritis due to pseudomonas in heroin addicts. J Bone Joint Surg Am. 1975;57:631–635.PubMedGoogle Scholar
  8. 8.
    Ho RC, Ho EC, Mak A. Cutaneous complications among i.v. buprenorphine users. J Dermatol. 2009;36:22–29.CrossRefPubMedGoogle Scholar
  9. 9.
    Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8:120.CrossRefPubMedGoogle Scholar
  10. 10.
    Kak V, Chandrasekar PH. Bone and joint infections in injection drug users. Infect Dis Clin North Am. 2002;16:681–695.CrossRefPubMedGoogle Scholar
  11. 11.
    Kido D, Bryan D, Halpern M. Hematogeneous osteomyelitis in drug addicts. Am J Roentgenol Radium Ther Nucl Med. 1973;118:356–363.PubMedGoogle Scholar
  12. 12.
    Levitsky S, Mammana RB, Silverman NA, Weber F, Hiro S, Wright RN. Acute endocarditis in drug addicts: surgical treatment for gram-negative sepsis. Circulation. 1982;66:I135–1138.PubMedGoogle Scholar
  13. 13.
    Lopez-Longo FJ, Menard HA, Carreno L, Cosin J, Ballesteros R, Monteagudo I. Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agents. J Rheumatol. 1987;14:991–994.PubMedGoogle Scholar
  14. 14.
    Miskew D, Lorenz M, Pearson R, Pankovich A. Pseudomonas aeruginosa bone and joint infections in drug abusers. J Bone Joint Surg Am. 1983;65:829–832.PubMedGoogle Scholar
  15. 15.
    Munoz-Fernandez S, Macia MA, Pantoja L, Cardenal A, Pena JM, Martin Mola E, Balsa A, Barbado FJ, Vazquez JJ, Gijon Banos J. Osteoarticular infection in intravenous drug abusers: influence of HIV infection and differences with non drug abusers. Ann Rheum Dis. 1993;52:570–574.CrossRefPubMedGoogle Scholar
  16. 16.
    Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, Edlin BR. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Office of National Drug Control Policy Web site. National Household Survey on Drug Abuse 2001. Available at: http://www.whitehousedrugpolicy.gov/drugfact/nhsda01.html. Accessed August 10, 2009.
  18. 18.
    Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop Relat Res. 1979;144:238–248.PubMedGoogle Scholar
  19. 19.
    Schnall SB, Holtom PD, Lilley JC. Abscesses secondary to parenteral abuse of drugs. A study of demographic and bacteriological characteristics. J Bone Joint Surg Am. 1994;76:1526–1530.PubMedGoogle Scholar
  20. 20.
    Shekar R, Rice TW, Zierdt CH, Kallick CA. Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago. J Infect Dis. 1985;151:203–208.PubMedGoogle Scholar
  21. 21.
    Summanen PH, Talan DA, Strong C, McTeague M, Bennion R, Thompson JE, Jr., Vaisanen ML, Moran G, Winer M, Finegold SM. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20 Suppl 2:S279–S282.PubMedGoogle Scholar
  22. 22.
    United Nations Office on Drugs and Crime Web site. World Drug Report 2009. Available at: http://viewer.zmags.com/publication/a8a299fc#/a8a299fc/1. Accessed August 10, 2009.
  23. 23.
    US Department of Health and Human Services Web site. National Survey on Drug Use and Health 2007. Available at: http://dx.doi.org/10.3886/ICPSR23782. Accessed August 10, 2009.

Copyright information

© The Association of Bone and Joint Surgeons® 2010

Authors and Affiliations

  • Daniel C. Allison
    • 1
  • Paul D. Holtom
    • 1
  • Michael J. Patzakis
    • 1
  • Charalampos G. Zalavras
    • 1
  1. 1.Department of Orthopaedic Surgery, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations